StonvexLoading…
StonvexStonvexStonvexCore line items from ASPI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.18M | $23.85M | $7.19M | $2.30M |
Operating Income | $-24.89M | $-59.91M | $-34.89M | $-19.92M |
Net Income | $-7.12M | $-159.84M | $-96.51M | $-75.16M |
EPS (Diluted) | $-0.06 | $-2.11 | $-1.27 | $-1.17 |
Total Assets | $587.67M | $498.02M | $225.89M | $135.91M |
Total Liabilities | $288.65M | $235.12M | $129.29M | $107.60M |
Cash & Equivalents | $207.35M | $279.57M | $113.90M | $67.70M |
Free Cash Flow OCF − CapEx | $-23.90M | $-47.43M | $-27.18M | $-15.18M |
Shares Outstanding | 125.90M | 111.68M | 93.38M | 83.91M |